Forward Citations = 76

Loading Chart...

4 inventors (with patents filed for the assignee):

Andrew Xian Chen (3 out of 36 patents)

Mannarsamy Balasubramanian (1 out of 16 patents)

Stewart V Smith (1 out of 3 patents)

4. R Martin Emanuele (1 out of 28 patents)

4 patents: Sort by Forward Citations

1. 9403941 - Poloxamer composition free of long circulating material and methods for production and uses thereof (2016-08-02),

2. 8557861 - Low oil emulsion compositions for delivering taxoids and other insoluble drugs (2013-10-15),

3. 8470873 - Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof (2013-06-25),

4. 8470346 - Anti-viral pharmaceutical compositions (2013-06-25),

Mast Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for serious or life-threatening diseases. The company’s lead product candidate is AIR001, a sodium nitrite solution for inhalation, which is being developed for the treatment of pulmonary arterial hypertension and heart failure with preserved ejection fraction.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#974 in San Diego, CA

#13,675 in California

#59,046 in US

San Diego, CA, United States of America

Mast Therapeutics, Inc.

Forward Citations = 76

4 inventors:

Andrew Xian Chen (3 out of 36 patents)

Mannarsamy Balasubramanian (1 out of 16 patents)

Stewart V Smith (1 out of 3 patents)

4. R Martin Emanuele (1 out of 28 patents)

Please report any incorrect information to support@idiyas.com